Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 646,074 shares, an increase of 230.7% from the May 14th total of 195,368 shares. Based on an average daily volume of 4,028,480 shares, the short-interest ratio is presently 0.2 days. Currently, 10.0% of the company’s shares are short sold.

Wall Street Analyst Weigh In

AMIX has been the topic of several research reports. Weiss Ratings lowered Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a research note on Wednesday, June 3rd. Zacks Research upgraded Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Finally, Maxim Group cut their price target on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $2.00.

Autonomix Medical Trading Down 2.3%

Shares of Autonomix Medical stock traded down $0.01 during trading on Friday, hitting $0.38. 64,531 shares of the stock traded hands, compared to its average volume of 932,960. The firm has a market cap of $2.63 million, a P/E ratio of -0.11 and a beta of -1.43. Autonomix Medical has a 52-week low of $0.20 and a 52-week high of $2.64. The stock’s fifty day simple moving average is $0.38 and its 200 day simple moving average is $0.48.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.